KSPHF Stock Price, Chart, Stats & News
Kissei Pharmaceutical Co., Ltd. (KSPHF) is a dividend-paying stock with a current dividend yield of 4.80% as of Aug 21, 2026. It pays $1.45 per share over the trailing twelve months. Its dividend has grown at a 23.75% 5-year compound annual rate.
Dividend safety
Dividend coverage is moderate for KSPHF — it pays out about 68% of earnings.
KSPHF chart
About
Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Calogra tablets, for the treatment of ulcerative colitis; Tabneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Corsuba Intravenous Dialysis Syringe for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which is in Phase III clinical trial for the treatment of uterine fibroids and endometriosis; KDT-3594, which is in Phase II clinical trial to treat Parkinson's disease; KSP-0243 that is in Phase II clinical trial to treat Ulcerative colitis; and Difelikefalin, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients.
Related lists
Similar securities
Based on sector and market capitalization
